Reach Us +19473334405
Molecular Study On The Potential Therapeutic Activity Of Novel Nanocomposite On Cancerous Tumor Bearing Mice | 63588
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

23rd Global Congress on Biotechnology

London, UK

International Conference on Biotechnology and Healthcare

Auckland, New Zealand
Share This Page

Molecular study on the potential therapeutic activity of novel nanocomposite on cancerous tumor bearing mice

Joint Event on 15th World Congress on Biotechnology And Biotech Industries Meet and 2nd International Conference on Enzymology and Molecular Biology

Mohammed F. EL-Shiekha

October 6 University, Egypt

Posters & Accepted Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.071

Nanoparticles are making significant contributions in the development of new approaches of drug delivery in cancer and can provide a platform for combined therapeutics with subsequent monitoring of response. Basic curcumin and zinc oxide (ZnO) nanocomposites modified with vitamin C and CTAB have been exerting chemo-preventative activity against cancer in mice animal model. The present results observed that nanocomposite have distinct effects on liver cell viability via killing cancer cells, while posing no effect on normal cells (hepatocytes). The marked difference in cytotoxicity between cancer cells and normal cells suggests an exciting potential for nanocomposite as novel alternatives to cancer therapy. Our molecular data showed that both mRNA and protein levels of tumor suppressor gene p53 were upregulated and induce activity of DNA fragmentation in liver cells.

Mohammed F El-Shiekha has completed his PhD from the Department of Biochemistry, Faculty of Veterinary Medicine, Benha University, Egypt. He is a Faculty Member in the Department of Biochemistry and pharmacy in October 6 University, Egypt. He has published 6 papers in reputed journals.

Email: [email protected]